stockrowGenerate Biomedicines, Inc. (GENB) vs Intellia Therapeutics, Inc. (NTLA)
- Generate Biomedicines, Inc. GENB 12.98 +3.26%
- Intellia Therapeutics, Inc. NTLA 11.27 +1.53%
Generate Biomedicines, Inc. and Intellia Therapeutics, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Generate Biomedicines, Inc. has the higher net margin (−781.1% vs −805.8%) and the higher return on invested capital (0.00% vs −195.3%). Across the 15 metrics below, Intellia Therapeutics, Inc. leads on 9 and Generate Biomedicines, Inc. on 6.
Valuation
Profitability
| Metric | GENB | NTLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (751.19%) | (821.24%) | 0.00% |
| Net margin | (781.10%) | (805.75%) | 0.00% |
| Free cash flow margin | (1,692.17%) | (671.57%) | 0.00% |
| Return on equity | 0.00% | (62.60%) | (51.96%) |
| Return on assets | (90.35%) | (46.63%) | (46.06%) |
| Return on invested capital | 0.00% | (195.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack